Status:
UNKNOWN
Validation of Chinese SRI Questionnaire
Lead Sponsor:
Guangzhou Institute of Respiratory Disease
Collaborating Sponsors:
Southern Medical University, China
Second Affiliated Hospital, Sun Yat-Sen University
Conditions:
Chronic Obstructive Pulmonary Disease
Hypercapnic Respiratory Failure
Eligibility:
All Genders
18-80 years
Brief Summary
Assessment of health-related quality of life in COPD patients with severe chronic respiratory failure requires appropriate and highly specific measurement tools. We attempt to validate the Chinese ver...
Eligibility Criteria
Inclusion
- Adult COPD Patients with chronic hypercapnic respiratory failure established on home noninvasive ventilation for at least 1 month
- Patients are in a clinically stable state,without any changes of medication during the previous 4 weeks.
Exclusion
- patient's refusal to participate
- Patients with evidence of acute respiratory failure i.e.patients with worsening of symptoms during the previous 2 weeks, a pH ,7.35, or with signs of respiratory infection
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2014
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT02240225
Start Date
January 1 2014
End Date
October 1 2014
Last Update
September 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangzhou Institute of Respiratory Disease
Guangzhou, Guangdong, China, 510120